טוען...
'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?
Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients. These, data together with the observations of diminished antiaggregatory response to as...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2535592/ https://ncbi.nlm.nih.gov/pubmed/18759979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-47 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|